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Abstract
Objective
A study was conducted to recover carbapenem-resistant bacteria from the faeces of dairy
cattle and identify the underlying genetic mechanisms associated with reduced phenotypic
susceptibility to carbapenems.
Methods
One hundred and fifty-nine faecal samples from dairy cattle were screened for carbape-
nem-resistant bacteria. Phenotypic screening was conducted on two media containing erta-
penem. The isolates from the screening step were characterised via disk diffusion, Modified
Hodge, and Carba NP assays. Carbapenem-resistant bacteria and carbapenemase-pro-
ducing isolates were subjected to Gram staining and biochemical testing to include Gram-
negative bacilli. Whole genome sequencing was performed on bacteria that exhibited either
a carbapenemase-producing phenotype or were not susceptible to ertapenem and were
presumptively Enterobacteriaceae.
Results
Of 323 isolates collected from the screening media, 28 were selected for WGS; 21 of which
were based on a carbapenemase-producing phenotype and 7 were presumptively Entero-
bacteriaceae and not susceptible to ertapenem. Based on analysis of WGS data, isolates
included: 3 Escherichia coli harbouring blaCMY-2 and truncated ompF genes; 8 Aeromonas
harbouring blacphA-like genes; 1 Acinetobacter baumannii harbouring a novel blaOXA gene
(blaOXA-497); and 6 Pseudomonas with conserved domains of various carbapenemase-pro-
ducing genes.
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Conclusions
Carbapenem resistant bacteria appear to be rare in cattle. Nonetheless, carbapenem-resis-
tant bacteria were detected across various genera and were found to harbour a variety of
mechanisms conferring reduced susceptibility. The development and dissemination of car-
bapenem-resistant bacteria in livestock would have grave implications for therapeutic treat-
ment options in human medicine; thus, continued monitoring of carbapenem susceptibility
among enteric bacteria of livestock is warranted.
Introduction
Carbapenems have become increasingly important as infections caused by pathogenic bacteria
resistant to practically all alternative antibiotics have become globally disseminated throughout
the past two decades [1, 2]. It is for this reason that carbapenems are reserved as the last resort
treatment of multi-drug resistant (MDR) infections in humans. Consequently, the spread of
carbapenem-hydrolysing enzymes among Enterobacteriaceae in hospital settings is of grave
concern [3–5]. Saliently, an estimated 9,300 healthcare-associated infections due to carbape-
nem-resistant Klebsiella and E. coli occurr in the United States (US) annually [6]. It is likely
that the emergence and dissemination of carbapenem-resistant Enterobacteriaceae (CRE) is
the consequence of increased reliance on carbapenems for treatment of MDR infections. More-
over, carbapenem resistance has become an urgent public health concern largely because CRE
are commonly co- or cross- resistant to all other clinically relevant antimicrobials; this, in turn,
drastically limits—or eliminates—alternative therapeutic options [6, 7].
Carbapenem resistance is generally mediated by two primary mechanisms: (i) production of
carbapenemases, enzymes (e.g. KPC, VIM, and OXA) capable of hydrolysing almost all β-lac-
tams or (ii) through modifications to the cell outer membrane, specifically by decreased cell
membrane permeability from porin modification, and/or production of efflux pumps; this is
often found in combination with cephalosporinase enzymes [7]. Carbapenemases are classified
into four different classes (Ambler classes A, B, C, and D) based on their mechanism of antibi-
otic hydrolysis [8]. The extent of resistance varies among enzymes in that KPC-1 and IMP-1
are commonly associated with resistance to typical therapeutic concentrations of carbapenems,
whereas OXA-23 is commonly associated with a reduced susceptibility to carbapenems based
on clinical interpretive criteria [9, 10].
In addition to clonal dissemination of CRB, carbapenemase-encoding genes are frequently
carried by mobile genetic elements, such as plasmids, and, as a result, carbapenemase encoding
genes have been reported across a variety of Enterobacteriaceae genera [11, 12]. Most clinically
relevant carbapenem resistance appear to have arisen and propagated as a result of clinical car-
bapenem use in human medicine [13]; consequently, our knowledge concerning the epidemiol-
ogy and ecology of carbapenem-resistant bacteria (CRB) is largely limited to human clinical
settings.
Carbapenems are not approved for use in livestock production anywhere in the world [14];
as a result, food-animal use is assumed to be rare. Despite—or perhaps because of—the lack of
direct selection pressure, little is known about the prevalence of CRB, and more specifically
CRE, in livestock populations and their associated environments. Even though there remains a
low probability of direct selection, CRB have been reported by investigators in a few instances;
for example blaVIM-1 was detected in Salmonella recovered from fattening pig farms and a
broiler farm in Germany [15], blaOXA-23 was detected in Acinetobacter isolated from dairy
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cattle in France and horses in Belgium [16, 17], and blaNDM-1 was detected in Acinetobacter iso-
lates from a chicken farm and from pigs in China [18, 19]. Despite robust existing integrated
antimicrobial resistance surveillance systems, surveillance of carbapenem resistance among
bacteria of livestock origin is in preliminary stages [20]. Given the high prevalence of co-resis-
tance to other antimicrobial classes among most clinically relevant CREs, it seems highly plau-
sible that, if introduced into livestock populations, CRE would further disseminate to humans
through animal contact, the environment, or food. It is important, therefore, to investigate
agricultural systems to detect and characterise carbapenem resistance among bacteria of animal
origin. The objectives of this project was to recover carbapenem-resistant bacteria (CRB) from
the faeces of dairy cattle and identify the underlying genetic mechanisms associated with
reduced phenotypic susceptibility to carbapenems.
Materials and Methods
Faecal sample collection
Pen-surface faecal samples were collected from a convenience sample of a dairy farm located in
southeastern NewMexico, US, and another dairy farm in the Texas Panhandle, US. Permission
from the owner of the private operations was received. As pen-floor fecal samples were collec-
tion, there was no interaction with vertebrate animals and no approval from an Institutional
Animal Care and Use Committee was needed. These dairy farms reported frequent historical
use of ceftiofur (a 3rd generation cephalosporin) and we have observed widespread prevalence
of genes encoding for AmpC and extended spectrum beta-lactamase (ESBL) enzymes among
Enterobacteriaceae (unpublished data). Samples were collected on multiple days fromMay to
July 2014 from pens housing healthy cows in early lactation (maximum 50 days in milk).
Selective isolation of CRB
Twenty-five grams of faeces were enriched in 225 mL of MacConkey broth (EMDMillipore,
Darmstadt, Germany) containing ertapenem (0.5 mg/L; Toronto Research Chemicals, Inc.,
Toronto, Canada), which was then hand homogenised before incubation at 37°C for 18 to 22
hours. Following incubation, 10 μL was streaked to two agar plates as an initial screening method
for CRB, one MacConkey agar (EMDMillipore) plate containing ertapenem (1.0 mg/L; ME) and
one modified-SUPERCARB (SC) agar plate. The ME agar was prepared as previously described
by Nordmann, Girlich, and Poirel [21]; however, due to the unavailability of Drigalski agar, Mac-
Conkey agar instead was used in the SC agar. In addition, the concentration of ertapenem was
raised from 0.25 mg/L to 0.5 mg/L, to reflect a change in interpretive criteria for ertapenem [10].
Phenotypic characterisation of CRB
One colony of each unique morphology was selected and streaked for isolation on tryptic soy
agar (EMDMillipore) containing ertapenem (0.5 mg/L; TSAe), which was then incubated for
18 to 22 hours at 37°C (S1 Fig). Isolates from the TSAe were screened in parallel utilising the
Modified Hodge test (MHT) and disk diffusion (DD) susceptibility test with an ertapenem-con-
taining disk (10 μg, BD BBL™ Sensi-Disc™, Sparks, MD) as previously described [10]. Isolates
were further characterised if they exhibited enhanced growth on MHT or else were not suscepti-
ble to ertapenem using the Clinical and Laboratory Standards Institute (CLSI) DD interpretive
criteria for Enterobacteriaceae, the initial genera targeted [10]. Intermediate and true clinical
resistance according to CLSI criteria will herein be described as resistance for simplicity. A
Gram stain was performed and presumptive species identification was obtained on all Gram-
negative bacilli using biochemical identification test kits specific for Enterobacteriaceae (API
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20E strips, Biomérieux, Marcy-l’Etoile, France) and Gram-negative organisms (Sensititre
GNID, TREK Diagnostic Systems Inc., Cleveland, OH). To confirm the carbapenemase-positive
phenotype, a pH-based test (Carba NP) was performed to confirm hydrolysis of the carbapenem
β-lactam as previously described [22]. Following genotypic exploration of genus (described
below), the DD results were later reinterpreted using the appropriate criteria where available (as
indicated in Table 1) [10]. As criteria have not yet been established for some complexes of Aero-
monas or for Pseudomonas spp. other than P. aeruginosa, CLSI criteria that are available were
used for reinterpretation of the A. allosaccharophila and Pseudomonas spp. isolates reported
herein. These values are not meant to imply clinical efficacy, but were interpreted to serve as a
phenotypic description in reference to better described relatives.
WGS and bioinformatics analyses
Whole-genome sequencing was performed for: (i) all potential CRE from all screening meth-
ods; and (ii) isolates of other families with a carbapenemase-producing phenotype (S1 Fig).
Genomic DNA was extracted (Bacterial Genomic Miniprep kit, Sigma-Aldrich, St. Louis, MO),
and paired-end libraries were generated (Nextera XT library kit v2, Illumina Inc., San Diego,
CA). The resulting libraries were sequenced using the sequencing by synthesis method on an
Illumina sequencing platform (MiSeq V.3.0, Illumina Inc., San Diego, CA) to obtain 300 bp
reads. A targeted genome coverage of 65x was used given an assumed mean genome size of 5
Mb for 28 isolates per run. Reads were assembled into draft genomes (A5 pipeline [23]) and
preliminarily annotated (Prokka [24]). The National Center for Biotechnology Information
Prokaryotic Genome Annotation Pipeline (NCBI PGAP [September 23, 2015]) was used for
the final genome annotation. Species identification was performed by calculating the average
nucleotide identity (ANIb) values between draft genomes obtained in this study and publicly
available reference genomes (JSpecies v1.2.1 [25]), and additional phylogenetic confirmation
using 16S sequences from draft genomes sequenced at Texas Tech University were compared
to type strains from the Ribosomal Database Project (https://rdp.cme.msu.edu/). Acinetobacter
baumannii and Escherichia coli isolates were further typed by multi-locus sequence typing
(MLST; MLST 1.8, Center for Genomic Epidemiology [CGE], Lyngby, Denmark). Isolates
were screened for antimicrobial resistance genes (SRST2 [26]) using the Antibiotic Resistance
Gene-ANNOTation tool (ARG-ANNOT [27]) database and the online tool ResFinder 2.1
(https://cge.cbs.dtu.dk//services/ResFinder/ [28]). Where no putative mechanisms of carbape-
nem resistance were identified, conserved domain BLASTs were performed using the Inte-
grated Toolkit for Exploration of microbial Pan-genomes (ITEP [29]) in order to identify
conserved domains associated with antibiotic resistance genes in other prokaryotes.
Outer membrane protein (OMP) gene sequences, specifically the ompF and ompC, were
extracted from the E. coli draft genomes sequenced in this study, as well as from a number of
reference genomes (Genbank U00096.3, CP008957.1, CP009072.1, NC_013361.1, and
HG428755.1). The OMP genes of the carbapenem-resistant E. coli were compared to the OMP
genes of the reference genomes to order to identify possible mutations, truncations, and inser-
tions that might affect protein function.
Results
From 159 faecal samples, a total of 151 and 172 isolates were collected from the SC and ME
plates, respectively. Of these 323 isolates, 163 isolates were deemed of interest as follows: 6
demonstrated a carbapenemase-producing phenotype on the MHT but were ertapenem-sus-
ceptible via DD, 142 were ertapenem-resistant via DD, and 15 demonstrated a carbapenemase-
producing, ertapenem-resistant phenotype. All DD interpretations at this stage were completed
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utilising the CLSI Enterobacteriaceae interpretive criteria as a screening method [10]. Within
these isolates of interest, 131 were Gram-negative bacilli and, by using the selection criteria (S1
Fig), 28 isolates from 21 pen-surface samples were selected for characterisation by WGS.
Twenty-one of the 28 isolates were selected based on a carbapenemase-producing phenotype
(regardless of its biochemical characterisation) and 7 presumptive CRE based on DD. Of the
isolates selected for WGS, a total of 17 and 11 isolates were collected from SC and ME agar
plates, respectively.
As a majority of the biochemical results lacked single genera exclusivity in their results (data
not reported), genome interrogation was used for final speciation; the isolates included Aero-
monas spp. (n = 18), A. baumannii (n = 1), Pseudomonas spp. (n = 6), and E. coli (n = 3;
Table 1. Phenotypic and genotypic description of the carbapenemase-producing or ertapenem non-susceptible isolates from dairy cattle faeces
that were subjected toWGS.
Isolate Mediaa Modifie Hodge
Test
Carb
NP
Disk
Diffusion
Taxonomic Designator (ANIb/
16S)
GenBank
Accession
Potential Mechanism of
resistance
008A SC 1 1 S* Pseudomonas citronellolis LKJO00000000 See S1 Table
011A SC 1 1 S* P. citronellolis LKKN00000000 See S1 Table
066A SC 0 — R* close to P. stutzeri LKKJ00000000 See S1 Table
080A SC 0 — R* close to P. anguillispectica LKKK00000000 See S1 Table
096B SC 0 — R* close to P. stutzeri LKKL00000000 See S1 Table
105A SC 1 1 S* close to P. stutzeri LKKM00000000 See S1 Table
108A ME 1 1 I Aeromonas veronii LKJN00000000 blacphA
108A SC 1 1 S A. veronii LKJP00000000 blacphA
113A ME 0 — I A. veronii LKJQ00000000 blacphA
115A ME 1 1 I A. veronii LKJR00000000 blacphA
115A SC 1 1 I A. veronii LKJS00000000 blacphA
120B ME 0 — R Escherichia coli ST-227b, ST-638c LKJT00000000 blaCMY-2 + TnompF + ompC
121A ME 0 — R E. coli ST-227b, ST-638c LKJU00000000 blaCMY-2 + TnompF + ompC
125A SC 1 1 I A. veronii LKJV00000000 blacphA
130A ME 1 1 S A. veronii LKJW00000000 blacphA
130A SC 1 1 R A. veronii LKJX00000000 blacphA
131A ME 1 1 I Acinetobacter baumannii ST-
1133b, ST-742c
LKJZ00000000 blaOXA-497
131A SC 1 1 R A. veronii LKJY00000000 blacphA
134A ME 1 1 I A. veronii LKKA00000000 blacphA
134A SC 1 1 I A. veronii LKKB00000000 blacphA
140A SC 1 1 R A. veronii LKKC00000000 blacphA
141A ME 1 1 R A. veronii LKKD00000000 blacphA
141A SC 1 1 R A. veronii LKKE00000000 blacphA
142A SC 1 1 R A. veronii LKKF00000000 blacphA
143A ME 1 1 R A. veronii LKKG00000000 blacphA
143A SC 1 1 R A. veronii LKKH00000000 blacphA
148A ME 0 — R E. coli ST-227b, ST-638c LKJM00000000 blaCMY-2 + TnompF + ompC
159A SC 1 1 S** Aeromonas allosaccharophila LKKI00000000 blacphA
a,SC, modified-SUPERCARBA media; ME, MacConkey agar containing ertapenem (1.0 mg/L)
b, Oxford scheme;
c, Pasteur scheme; 0, carbapenemase-negative; 1, carbapenemase-positive;—, test not performed; S, susceptible; I, intermediate; R, resistant.
*, Interpreted using CLSI carbapenem breakpoints established for Pseudomonas aeruginosa;
**, interpreted using CLSI carbapenem breakpoint established for Aeromonas spp.; Tn, premature stop codon.
doi:10.1371/journal.pone.0147363.t001
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Table 1). The sequence types (ST) of all E. coli isolates (n = 3) were identical; that is, either ST-
227 (n = 3) or ST-638 (n = 3) depending on the typing scheme used, Oxford or Pasteur [30,
31], respectively. All 3 E. coli isolates harboured the AmpC β-lactamase gene blaCMY-2. Com-
parison of the ompF gene sequences in all 3 E. coli isolates to reference sequences revealed a sin-
gle base pair insertion at position 373 that resulted in a frameshift and; thus, a predicted
premature stop codon in the protein leading to a truncated 128 amino acid OmpF (compared
to 362 amino acids of the reference strains). Two of the three E. coli isolates (120BME and
121AME) showed 100% similarity in their ompC amino acid sequences and no predicted pre-
mature stop codons were identified. The genomic region containing ompC in the remaining E.
coli isolate (148AME) could not be adequately assembled.
A carbapenemase-producing phenotype was observed in the single A. baumannii and this
isolate was of a novel ST designated ST-1133 and ST-742 based on the Oxford [32] and Pasteur
[33] scheme, respectively (PubMLST database; http://pubmlst.org, date: October 21, 2015 and
September 11, 2015). This isolate harboured an Ambler class D carbapenemase that is part of
the OXA-51-like enzyme group (S3 Fig) with 5 nucleotide changes that yield 3 amino acid
changes (N111D, D123N, and E227G) from the previously described blaOXA-379 (KF986260).
The observed blaOXA β-lactamase gene appeared to be novel and was designated blaOXA-497
(Lahey β-lactamase database; http://www.lahey.org/Studies/, date: July 8, 2015). It was found in
a contig that has high sequence similarity to the sequence of chromosome A. baumannii
CIP70.10 (LN865143.1) and genes flanking blaOXA-497 did not show similarity to transposable
elements (e.g. insertion sequences). The isolate exhibited intermediate resistance to ertapenem
using clinical interpretive DD criteria for the Acinetobacter spp [10].
Eighteen Aeromonas isolates were sequenced; 17 harboured a carbapenemase-producing
phenotype that was initially observed on the MHT and was subsequently confirmed with the
Carba NP assay. The remaining isolate showed biochemical and phenotypic characteristics of a
CRE. Following genome sequencing, 17 isolates were identified as A. veronii and one isolate as
A. allosaccharophila; the latter isolate exhibited a carbapenemase-producing phenotype, but
was susceptible to ertapenem via DD using interpretive criteria for Aeromonas spp. of the A.
caviae, A. hydrophila, and A. veronii complexes [34]. All of the A. veronii isolates harboured a
blacphA-like gene in a highly conserved part of the chromosome, although three allele variations
of this gene were identified (S2 Fig).
Of the 6 Pseudomonas isolates, 2, 3 and 1 were identified as P. citronellolis, a putatively
undescribed species closely related to P. stutzeri, and a putatively undescribed species closely
related to P. anguillispectica, respectively. Three of these Pseudomonas isolates were considered
of interest due to presumptive carbapenemase production (008ASC, 011ASC, and 105ASC),
while the remaining three were speculated to be presumptive CRE based on disk diffusion and
biochemical characterisation. The initial biochemical findings suggested the possibility that
they belonged to the Enterobacteriaceae family; however, these were subsequently identified as
Pseudomonas spp. based on analysis of sequence data. When utilising the interpretative criteria
for P. aeruginosa, the non-carbapenemase-producing isolates had a reduced susceptibility to
ertapenem, whereas those with a carbapenemase-positive phenotype exhibited susceptibility.
Identified conserved domains of genes included those encoding Ambler class B (blaIMP), class
C (blaampC), and class D (blaOXA) β-lactamases; yet their role in the observed phenotypes
remains uncertain (S1 Table).
Discussion
In this study, we recovered CRB from cattle faeces. Whereas we did not attempt to identify dis-
semination beyond the dairy farms, our find warrants further consideration of the diversity of
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CRB on dairies. We selected the 2 dairy farms based on frequent ceftiofur use and previously
observed frequency of AmpC and ESBL gene harbourage among Enterobacteriaceae bacteria
(unpublished data). We hypothesised, therefore, that the selective pressure of ceftiofur use [35]
may have favoured dissemination of these β-lactamases and might also select for carbapene-
mases, if present. While our report is not intended to be generalised to the wider population of
dairy cattle, it does provide novel insights into the diversity of carbapenem-resistance mecha-
nisms and the diversity of bacteria that harbour them in agricultural environments.
Our initial goal was to detect carbapenem resistance among Enterobacteriaceae and we were
able to identify 3 CRE isolates of E. coli species from 159 samples; hence, we conclude that the
burden of CRE is extremely low. Moreover, these CRE were negative for carbapenemase pro-
duction and their expressed phenotypic resistance might be due to a multifactorial mechanism.
The combined presence of blaCMY-2 and a lack of OmpF and OmpC have been previously asso-
ciated with imipenem resistance in E. coli [36, 37]; however, a more recent report refutes the
involvement of OmpC in carbapenem-resistance and suggests that there may be other
unknown mechanisms [38]. In the recovered E. coli, we were able to confirm the presence of a
blaCMY-2 and a premature stop codon in the ompF; although the clinical importance of these
carbapenemase-negative CRE to human health outcomes remains uncertain.
While not included in our initial goal, we also identified carbapenemase-producing bacteria
among non-Enterobacteriaceae families. These were included based on our decision tree (S1
Fig); for some, biochemical test results indicated the possibility that these isolates belonged to
the Enterobacteriaceae family. While our biochemical assays might not always have provided
conclusive identification, it enabled us to characterise carbapenemase enzymes or carbapenem-
resistance among a diverse set of bacteria. In particular, we recovered an A. baumannii har-
bouring a novel blaOXA gene (blaOXA-497) that appears to be chromosomally encoded, thus pre-
sumably likely to be transferred than if associated with genetic mobile elements, such as
plasmids or insertion sequences. Carbapenemase activity by blaOXA enzymes can vary as the
activity can depend on the extent of gene expression and/or the presence of other resistance
mechanisms, such as decreased permeability or efflux [39]. Future investigations to character-
ise this isolate and to describe the potential mobilisation of blaOXA-497 and its extent of expres-
sion are underway. In addition to A. baumannii, we recovered many Aeromonas isolates
harbouring a blacphA-type metallo-β-lactamase, which are reported to be common among A.
veronii [40, 41]. The genes encoding cphA-type enzymes are on the chromosome; thus, they
might be of less epidemiologically relevance to the dissemination of genes that hydrolyse
carbapenems.
In some of the recovered Pseudomonas isolates, conserved domains of blaIMP- and blaOXA-
like genes were identified that could represent an acquired ability to produce carbapenemases
of clinical importance. Compared to P. aeruginosa, little is known about antimicrobial resis-
tance in other species of Pseudomonas; thus, it is difficult to make inferences regarding the
potential clinical importance of these isolates [10, 42]. Furthermore, there are no clinical inter-
pretive criteria for pseudomonads other than P. aeruginosa. Interestingly, the presence of con-
served domains of carbapenemase-producing phenotype did not always align with the
carbapenemase-producing phenotype. While we find proteins with these conserved domains,
these proteins appear to have a different function. This could also be due to a discrepancy in
the phenotypic result or the presences of unidentified mechanisms conferring carbapenemase
production [43, 44].
An important consideration is that universally accepted phenotypic methods to recover and
characterise carbapenem resistant (or at least, non-susceptible) bacteria are in early stages of
development and, thus, limitations were inherent in the methods used in our study. First, the
concentration of ertapenem in the enrichment and selective media may have been too great for
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isolation of some carbapenemase-producing bacteria; in particular, bacteria producing OXA-
like enzymes that have been associated with low-level resistance—due to their weak ability to
hydrolyse carbapenems—might not have been recovered [45, 46]. In addition, as our scope of
interest broadened posteriori to include Aeromonas spp., Acinetobacter spp., and Pseudomonas
spp., screening with an alternative carbapenem may have been more appropriate as ertapenem
exhibits poor activity on the latter two genera [43, 47]. Finally, the carbapenemase screening
method used (the MHT) has been associated with interpretation challenges that include both
false-positive and false-negative results [10, 48, 49]. In this study, the Carba NP test was used
to confirm carbapenemase production after the MHT; however, it is possible that some carba-
penemase-producing bacteria may have been wrongfully disregarded due to interpretation
error on the MHT.
Based on the results described herein—and despite the limitations of the study, CRE appear
to be very rare among dairy cattle in the High Plains of the USA. Nevertheless, CRB were pres-
ent in the dairy cattle population sampled. Importantly, many of the carbapenemase genes rec-
ognised for their rapid acquisition and dissemination throughout hospital-settings worldwide,
e.g. variants of blaKPC or blaNDM [50], were not found. Despite this, we described a diverse set
of bacteria and mechanisms that conferred resistance to carbapenems. These results, therefore,
highlight the need for effective approaches to avoid the introduction of clinically relevant
genetic elements into cattle populations, and to prevent the emergence of carbapenem resistant
determinants in livestock populations through co-selection with other commonly used antimi-
crobials. Further, we believe there is need for on-going or periodic surveillance of CRB in live-
stock populations. Clearly, this is contingent on the development of methods with sensitivity
and specificity for all types of carbapenemase enzymes. Molecular methods may offer advan-
tages as alternative approaches for the detection of antimicrobial resistance genes; however,
given the diversity of genetic mechanisms identified, isolate-based genomic interrogation is
still warranted.
Supporting Information
S1 Fig. Decision tree used to determine inclusion criteria for carbapenem-resistant isolates
collected from dairy cattle faeces.
(PDF)
S2 Fig. Phylogeny demonstrating variation of cphA gene in Aeromonas isolates found in
this study. Sequences of cphA were aligned using Muscle version 3.8.31 (Edgar, RC. 2004.
Nucleic Acids Research, 32(5), 1792–1797) and a parsimony based phylogeny was inferred
using PAUPversion 4.0b10 (Wilgenbusch, J. C., & Swofford, D. (2003). Current Protocols in
Bioinformatics / Editoral Board, Andreas D Baxevanis [Et Al], Chapter 6, Unit 6.4. http://doi.
org/10.1002/0471250953 bi0604s00), using the heuristic search option. Values on the branches
are the inferred number of steps (single nucleotide substitutions). The search resulted in 1 tree
(317 steps, C.I. = 0.647). Values below the branches indicate bootstrap values based on 500 rep-
licates, values below< 50 are not shown.
(PDF)
S3 Fig. Maximum likelihood phylogenies of representative OXA- types and OXA-51-like
nucleotide sequences (inset) including the novel OXA-497 (marked in red). Nucleotide
sequences were aligned using an amino acid sequence guided strategy using TranslatorX
(Abascal et al. 2010. Nucleic Acids Research, 38 Web Server issue), W7–13. http://doi.org/10.
1093/nar/gkq291), phylogenies were inferred using RAxML version 8.1.20 (Stamatakis, A.
2014. Bioinformatics 30(9), 1312–1313. http://doi.org/10.1093/bioinformatics/btu033). Values
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on the branches represent bootstrap values as inferred using the autoFC bootstopping option
(Pattengale et al. 2010, Journal of Computational Biology: a Journal of Computational Molecu-
lar Cell Biology, 17(3), 337–354. http://doi.org/10.1089/cmb.2009.0179).
(PDF)
S1 Table. Overview of putative beta-lactamase like genes in Pseudomonas spp. found by
conserved domain searches.
(DOCX)
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